Literature DB >> 32371472

SARS-CoV-2 and ORF3a: Nonsynonymous Mutations, Functional Domains, and Viral Pathogenesis.

Elio Issa1, Georgi Merhi1, Balig Panossian1, Tamara Salloum1, Sima Tokajian2.   

Abstract

The effect of the rapid accumulation of nonsynonymous mutations on the pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is not yet known. The 3a protein is unique to SARS-CoV and is essential for disease pathogenesis. Our study aimed at determining the nonsynonymous mutations in the 3a protein in SARS-CoV-2 and determining and characterizing the protein's structure and spatial orientation in comparison to those of 3a in SARS-CoV. A total of 51 different nonsynonymous amino acid substitutions were detected in the 3a proteins among 2,782 SARS-CoV-2 strains. We observed microclonality within the ORF3a gene tree defined by nonsynonymous mutations separating the isolates into distinct subpopulations. We detected and identified six functional domains (I to VI) in the SARS-CoV-2 3a protein. The functional domains were linked to virulence, infectivity, ion channel formation, and virus release. Our study showed the importance of conserved functional domains across the species barrier and revealed the possible role of the 3a protein in the viral life cycle. Observations reported in this study merit experimental confirmation.IMPORTANCE At the surge of the coronavirus disease 2019 (COVID-19) pandemic, we detected and identified six functional domains (I to VI) in the SARS-CoV-2 3a protein. Our analysis showed that the functional domains were linked to virulence, infectivity, ion channel formation, and virus release in SARS-CoV-2 3a. Our study also revealed the functional importance of conserved domains across the species barrier. Observations reported in this study merit experimental confirmation.
Copyright © 2020 Issa et al.

Entities:  

Keywords:  3a protein; COVID-19; ORF3a; SARS-CoV-2; nonsynonymous mutations

Year:  2020        PMID: 32371472     DOI: 10.1128/mSystems.00266-20

Source DB:  PubMed          Journal:  mSystems        ISSN: 2379-5077            Impact factor:   6.496


  81 in total

1.  Variants in SARS-CoV-2 associated with mild or severe outcome.

Authors:  Jameson D Voss; Martin Skarzynski; Erin M McAuley; Ezekiel J Maier; Thomas Gibbons; Anthony C Fries; Richard R Chapleau
Journal:  Evol Med Public Health       Date:  2021-06-27

2.  Global analysis of more than 50,000 SARS-CoV-2 genomes reveals epistasis between eight viral genes.

Authors:  Hong-Li Zeng; Vito Dichio; Edwin Rodríguez Horta; Kaisa Thorell; Erik Aurell
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-17       Impact factor: 11.205

3.  Genomic Variations in SARS-CoV-2 Genomes From Gujarat: Underlying Role of Variants in Disease Epidemiology.

Authors:  Madhvi Joshi; Apurvasinh Puvar; Dinesh Kumar; Afzal Ansari; Maharshi Pandya; Janvi Raval; Zarna Patel; Pinal Trivedi; Monika Gandhi; Labdhi Pandya; Komal Patel; Nitin Savaliya; Snehal Bagatharia; Sachin Kumar; Chaitanya Joshi
Journal:  Front Genet       Date:  2021-03-19       Impact factor: 4.599

4.  Modeling the binding of protoporphyrin IX, verteporfin, and chlorin e6 to SARS-CoV-2 proteins.

Authors:  Oskar I Koifman; Natalia Sh Lebedeva; Yury A Gubarev; Mikhail O Koifman
Journal:  Chem Heterocycl Compd (N Y)       Date:  2021-05-14       Impact factor: 1.277

Review 5.  SARS-CoV-2 mutations: the biological trackway towards viral fitness.

Authors:  Parinita Majumdar; Sougata Niyogi
Journal:  Epidemiol Infect       Date:  2021-04-30       Impact factor: 2.451

6.  Host- and Species-Dependent Quasispecies Divergence of Severe Acute Respiratory Syndrome Coronavirus-2 in Non-human Primate Models.

Authors:  Eun-Ha Hwang; Hoyin Chung; Green Kim; Hanseul Oh; You Jung An; Philyong Kang; Choong-Min Ryu; Jong-Hwan Park; Jungjoo Hong; Bon-Sang Koo
Journal:  Front Microbiol       Date:  2021-07-09       Impact factor: 5.640

7.  The Immunopathobiology of SARS-CoV-2 Infection.

Authors:  Milankumar Patel; Farah Shahjin; Jacob D Cohen; Mahmudul Hasan; Jatin Machhi; Heerak Chugh; Snigdha Singh; Srijanee Das; Tanmay A Kulkarni; Jonathan Herskovitz; Douglas D Meigs; Ramesh Chandra; Kenneth S Hettie; R Lee Mosley; Bhavesh D Kevadiya; Howard E Gendelman
Journal:  FEMS Microbiol Rev       Date:  2021-11-23       Impact factor: 16.408

Review 8.  SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns.

Authors:  Natalia Redondo; Sara Zaldívar-López; Juan J Garrido; Maria Montoya
Journal:  Front Immunol       Date:  2021-07-07       Impact factor: 7.561

9.  Relevant SARS-CoV-2 Genome Variation through Six Months of Worldwide Monitoring.

Authors:  Abdelmalek Hakmaoui; Faisal Khan; Abdelhamid Liacini; Amanjot Kaur; Yacine Berka; Safaa Machraoui; Hafid Soualhine; Noureddine Berka; Hanane Rais; Brahim Admou
Journal:  Biomed Res Int       Date:  2021-06-29       Impact factor: 3.411

10.  The First Molecular Characterization of Serbian SARS-CoV-2 Isolates From a Unique Early Second Wave in Europe.

Authors:  Danijela Miljanovic; Ognjen Milicevic; Ana Loncar; Dzihan Abazovic; Dragana Despot; Ana Banko
Journal:  Front Microbiol       Date:  2021-06-18       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.